Highlight
Summary
About the Role
About You
- MD or equivalent degree with accredited residency training and board certification in Neurology; subspecialization preferred.
- 8+ years of experience in clinical drug development (Phase 1-3) in a pharmaceutical/biotechnology company, including significant experience in a senior leadership role.
- Extensive knowledge of clinical drug development, including planning, regulatory requirements, study design, and Good Clinical Practice (GCP).
- Advanced degree (MS, PhD) in a relevant scientific discipline.
- Demonstrated success in leading clinical programs in neurodegenerative diseases, particularly in Alzheimer disease and Parkinson disease.
- Experience in developing various treatment modalities, including small molecules and biologic/genetic therapies.
Benefits
- Annual base salary range of $314k–$455k.
- Annual bonus target of 35% of the earned base salary.
- Eligibility to participate in equity-based long-term incentive program.
- Retirement savings plan with company match.
- Paid vacation, holiday, and personal days.
- Paid caregiver/parental and medical leave.
- Health benefits including medical, prescription drug, dental, and vision coverage.
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines *in collaboration with AbbVie